JP2023532852A5 - - Google Patents

Info

Publication number
JP2023532852A5
JP2023532852A5 JP2022578860A JP2022578860A JP2023532852A5 JP 2023532852 A5 JP2023532852 A5 JP 2023532852A5 JP 2022578860 A JP2022578860 A JP 2022578860A JP 2022578860 A JP2022578860 A JP 2022578860A JP 2023532852 A5 JP2023532852 A5 JP 2023532852A5
Authority
JP
Japan
Prior art keywords
antigen
isolated antibody
cancer
amino acid
acid sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022578860A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023532852A (ja
JP7854948B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/040445 external-priority patent/WO2022010847A1/en
Publication of JP2023532852A publication Critical patent/JP2023532852A/ja
Publication of JP2023532852A5 publication Critical patent/JP2023532852A5/ja
Priority to JP2025169285A priority Critical patent/JP2026021336A/ja
Application granted granted Critical
Publication of JP7854948B2 publication Critical patent/JP7854948B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022578860A 2020-07-07 2021-07-06 Ｍｉｃ抗体及び結合剤ならびにそれらの使用方法 Active JP7854948B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025169285A JP2026021336A (ja) 2020-07-07 2025-10-07 Ｍｉｃ抗体及び結合剤ならびにそれらの使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063049012P 2020-07-07 2020-07-07
US63/049,012 2020-07-07
PCT/US2021/040445 WO2022010847A1 (en) 2020-07-07 2021-07-06 Mic antibodies and binding agents and methods of using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025169285A Division JP2026021336A (ja) 2020-07-07 2025-10-07 Ｍｉｃ抗体及び結合剤ならびにそれらの使用方法

Publications (3)

Publication Number Publication Date
JP2023532852A JP2023532852A (ja) 2023-08-01
JP2023532852A5 true JP2023532852A5 (cg-RX-API-DMAC7.html) 2024-07-10
JP7854948B2 JP7854948B2 (ja) 2026-05-07

Family

ID=

Similar Documents

Publication Publication Date Title
IL276830B1 (en) Anti-claudin 18.2 antibodies and their uses
JP7785284B2 (ja) Ｃｄ３８抗体とｉｃａｍ１抗体およびそれらの使用
JP2021524249A5 (cg-RX-API-DMAC7.html)
JP2021514664A5 (cg-RX-API-DMAC7.html)
JP2019500891A5 (cg-RX-API-DMAC7.html)
JP2019500892A5 (cg-RX-API-DMAC7.html)
JP2020534351A5 (cg-RX-API-DMAC7.html)
JP2023516004A5 (cg-RX-API-DMAC7.html)
JP2021515541A5 (cg-RX-API-DMAC7.html)
JP2020522280A5 (cg-RX-API-DMAC7.html)
RU2017114968A (ru) Связывающие молекулы, а именно антитела, способные связываться с l1cam (cd171)
JP2020522281A5 (cg-RX-API-DMAC7.html)
JP2023543826A5 (cg-RX-API-DMAC7.html)
JP2024540148A5 (cg-RX-API-DMAC7.html)
JP2023516724A5 (cg-RX-API-DMAC7.html)
JP2021515542A5 (cg-RX-API-DMAC7.html)
JP2022553908A5 (cg-RX-API-DMAC7.html)
US20250277054A1 (en) Psma antibodies and uses thereof
JP2025504795A5 (cg-RX-API-DMAC7.html)
CN109071671B (zh) Erbb2靶向抗体
JP2025504496A5 (cg-RX-API-DMAC7.html)
JP2024519078A5 (cg-RX-API-DMAC7.html)
JP2024522075A5 (cg-RX-API-DMAC7.html)
JP2021514654A5 (cg-RX-API-DMAC7.html)
JP2023532852A5 (cg-RX-API-DMAC7.html)